Junqi Luo
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- Ferroptosis and cancer prognosis
Papers in ⓘ
-
- Circular RNAs in diseases 3
- RNA modifications and cancer 2
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
- Co-authors
- Taowei Yang (8 shared papers)Wenbin Chen (7 shared papers)Xumin Zhou (7 shared papers)Libin Zou (6 shared papers)Kaihui Wu (6 shared papers)Shengren Cen (5 shared papers)Fangpeng Shu (6 shared papers)Xiangming Mao (4 shared papers)
- Journals
- Cell Death and Disease (2 papers)Pharmacological Research (1 paper)Acta Pharmaceutica Sinica B (1 paper)Cell Death Discovery (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Junqi Luo
9 papers receiving 356 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 218
- Pulmonary and Respiratory Medicine 125
- Molecular Biology 255
- Oncology 45
- Immunology 32
Countries citing papers authored by Junqi Luo
This map shows the geographic impact of Junqi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqi Luo more than expected).
Fields of papers citing papers by Junqi Luo
This network shows the impact of papers produced by Junqi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqi Luo. The network helps show where Junqi Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Junqi Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 78 | |
| 2 | 2020 | 73 | |
| 3 | 2021 | 41 | |
| 4 | 2023 | 40 | |
| 5 | 2021 | 40 | |
| 6 | 2022 | 33 | |
| 7 | 2021 | 33 | |
| 8 | 2021 | 20 | |
| 9 | 2025 | 2 |
About Junqi Luo
Junqi Luo is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Rheumatology, having authored 9 papers that have together received 360 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), Cancer-related molecular mechanisms research (3 papers), Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (2 papers), Prostate Cancer Treatment and Research (2 papers), RNA modifications and cancer (2 papers), Luminescence and Fluorescent Materials (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Cancer Research (218 citations), Pulmonary and Respiratory Medicine (125 citations), Molecular Biology (255 citations), Oncology (45 citations) and Immunology (32 citations). Junqi Luo has collaborated with scholars based in China and United States. Frequent co-authors include Taowei Yang, Wenbin Chen, Xumin Zhou, Libin Zou, Kaihui Wu, Shengren Cen, Fangpeng Shu, Xiangming Mao, Daojun Lv and Xiangming Mao. Their work appears in journals such as Cell Death and Disease, Pharmacological Research, Acta Pharmaceutica Sinica B, Cell Death Discovery and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.